Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001113148-20-000004
Filing Date
2020-03-03
Accepted
2020-03-03 15:56:21
Documents
87
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K infi-1231201910xk.htm 10-K 1612949
2 EXHIBIT 4.2 exhibit42descriptionofcs.htm EX-4.2 23476
3 EXHIBIT 10.15 exhibit1015fundingagreement.htm EX-10.15 418705
4 EXHIBIT 10.16 exhibit1016fundingagreemen.htm EX-10.16 152780
5 EXHIBIT 10.35 exhibit10352013esppasamend.htm EX-10.35 72051
6 EXHIBIT 21.1 exhibit2112019.htm EX-21.1 5217
7 EXHIBIT 23.1 exhibit231eyconsent2019.htm EX-23.1 11400
8 EXHIBIT 31.1 exhibit3112019.htm EX-31.1 12648
9 EXHIBIT 31.2 exhibit3122019.htm EX-31.2 12624
10 EXHIBIT 32.1 exhibit3212019.htm EX-32.1 8382
11 EXHIBIT 32.2 exhibit3222019.htm EX-32.2 8084
18 GRAPHIC checkmate275.jpg GRAPHIC 36623
19 GRAPHIC ipi549moa.jpg GRAPHIC 148283
20 GRAPHIC mdscsm2tams.jpg GRAPHIC 160406
21 GRAPHIC pipelinew2020goals.jpg GRAPHIC 225391
  Complete submission text file 0001113148-20-000004.txt   7824638

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT infi-20191231.xml EX-101.INS 930438
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20191231.xsd EX-101.SCH 67340
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20191231_cal.xml EX-101.CAL 87421
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20191231_def.xml EX-101.DEF 269148
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20191231_lab.xml EX-101.LAB 769398
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20191231_pre.xml EX-101.PRE 428553
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31141 | Film No.: 20682030
SIC: 2834 Pharmaceutical Preparations